[
  {
    "title": "Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down",
    "published": 1713070860,
    "posting_price": 186.26350629,
    "close_price": 183.4291687,
    "percent_change": -1.52168165
  },
  {
    "title": "Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities",
    "published": 1712984592,
    "posting_price": 186.26350629,
    "close_price": 183.4291687,
    "percent_change": -1.52168165
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: InMode (INMD), Resmed (RMD)",
    "published": 1712926260,
    "posting_price": 186.92748955,
    "close_price": 184.19226074,
    "percent_change": -1.46325659
  },
  {
    "title": "Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",
    "published": 1712924520,
    "posting_price": 186.92748955,
    "close_price": 184.19226074,
    "percent_change": -1.46325659
  },
  {
    "title": "ResMed Inc (RMD)'s Winning Formula: Financial Metrics and Competitive Strengths",
    "published": 1712743380,
    "posting_price": 189.00864016,
    "close_price": 192.06100464,
    "percent_change": 1.61493383
  },
  {
    "title": "Mizuho sees ResMed as 'overwhelming beneficiary' of Philips consent decree",
    "published": 1712718120,
    "posting_price": 189.00864016,
    "close_price": 192.06100464,
    "percent_change": 1.61493383
  },
  {
    "title": "Mizuho sees ResMed as \"overwhelming beneficiary\" of Philips consent decree",
    "published": 1712717400,
    "posting_price": 189.00864016,
    "close_price": 192.06100464,
    "percent_change": 1.61493383
  },
  {
    "title": "ResMed: Not A Sleeper",
    "published": 1712485316,
    "posting_price": 186.91758951,
    "close_price": 186.07521057,
    "percent_change": -0.45066863
  },
  {
    "title": "ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024",
    "published": 1712261100,
    "posting_price": 185.91665713,
    "close_price": 183.33998108,
    "percent_change": -1.38593071
  },
  {
    "title": "Resmed Inc Reports Increased CDIs in March",
    "published": 1712206200,
    "posting_price": 185.91665713,
    "close_price": 183.33998108,
    "percent_change": -1.38593071
  },
  {
    "title": "5 Medical Product Stocks to Buy Amid Industry Challenges",
    "published": 1712061300,
    "posting_price": 185.90673163,
    "close_price": 182.70571899,
    "percent_change": -1.72183794
  },
  {
    "title": "ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript",
    "published": 1714498261,
    "posting_price": 213.10050074,
    "close_price": 212.06983948,
    "percent_change": -0.48365032
  },
  {
    "title": "Why ResMed (RMD) is a Top Momentum Stock for the Long-Term",
    "published": 1714485012,
    "posting_price": 213.10050074,
    "close_price": 212.06983948,
    "percent_change": -0.48365032
  },
  {
    "title": "ResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next",
    "published": 1714471962,
    "posting_price": 213.10050074,
    "close_price": 212.06983948,
    "percent_change": -0.48365032
  },
  {
    "title": "(RMD) - Analyzing ResMed's Short Interest",
    "published": 1714467000,
    "posting_price": 213.10050074,
    "close_price": 212.06983948,
    "percent_change": -0.48365032
  },
  {
    "title": "Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78",
    "published": 1714451940,
    "posting_price": 213.10050074,
    "close_price": 212.06983948,
    "percent_change": -0.48365032
  },
  {
    "title": "Top Stocks to Buy with Rising EPS Estimates After Earnings",
    "published": 1714425420,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "ResMed : Q3 2024 ResMed Earnings Results Webcast Transcript",
    "published": 1714421948,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "Looking for a Growth Stock? 3 Reasons Why ResMed (RMD) is a Solid Choice",
    "published": 1714409105,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down",
    "published": 1714408380,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "Here's Why ResMed (RMD) is a Strong Growth Stock",
    "published": 1714398311,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "Video: S&P 500 Movers: RMD, TSLA",
    "published": 1714382640,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "ResMed Reaches Analyst Target Price",
    "published": 1714379580,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "Morgans rates RMD as Add",
    "published": 1714343467,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "ResMed Inc. Files Compliant Quarterly Report",
    "published": 1714282080,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "ResMed price target raised by $15 at UBS, here's why",
    "published": 1714273500,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "Decoding ResMed Inc (RMD): A Strategic SWOT Insight",
    "published": 1714194369,
    "posting_price": 212.18876998,
    "close_price": 215.24113464,
    "percent_change": 1.43851376
  },
  {
    "title": "How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed",
    "published": 1714154455,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Top Midday Gainers",
    "published": 1714155163,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Integer Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up",
    "published": 1714151220,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Why ResMed Stock Is Soaring Today",
    "published": 1714147737,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed Stock Jumps After Earnings, Revenue Beats",
    "published": 1714146300,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes",
    "published": 1714140055,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Are Medical Stocks Lagging  OrganiGram (OGI) This Year?",
    "published": 1714138811,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand",
    "published": 1714135020,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better.",
    "published": 1714134780,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Q3 2024 Resmed Inc Earnings Call",
    "published": 1714127585,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed Inc's Meteoric Rise: Unpacking the 12% Surge in Just 3 Months",
    "published": 1714126620,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed declares $0.48 dividend",
    "published": 1714123800,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Early notable gainers among liquid option names on April 26th",
    "published": 1714121700,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed price target lowered by $5 at Oppenheimer, here's why",
    "published": 1714117980,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed Analysts Boost Their Forecasts After Better-Than-Expected Earnings",
    "published": 1714117800,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed price target raised by $12 at Needham, here's why",
    "published": 1714117320,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed Inc (RMD) Q3 2024 Earnings Call Transcript Highlights: Strong Financial Performance and ...",
    "published": 1714116961,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed price target raised by $13 at RBC Capital, here's why",
    "published": 1714114800,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet",
    "published": 1714110780,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "RBC Capital Sticks to Their Hold Rating for Resmed (RMD)",
    "published": 1714109880,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "ResMed price target raised by $11 at KeyBanc, here's why",
    "published": 1714109820,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More",
    "published": 1714108320,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)",
    "published": 1714108320,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)",
    "published": 1714107840,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months",
    "published": 1714101660,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "KeyBanc Keeps Their Buy Rating on Resmed (RMD)",
    "published": 1714095120,
    "posting_price": 201.19827976,
    "close_price": 216.10331726,
    "percent_change": 7.40813367
  },
  {
    "title": "Compared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics",
    "published": 1714084208,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed Inc (RMD) Q3 Fiscal 2024 Earnings: Surpasses Analyst Expectations with Strong Growth",
    "published": 1714081407,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed Inc. 2024 Q3 - Results - Earnings Call Presentation",
    "published": 1714081118,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed Inc. (RMD) Q3 2024 Earnings Call Transcript",
    "published": 1714081082,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates",
    "published": 1714080306,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024",
    "published": 1714075500,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed: Fiscal Q3 Earnings Snapshot",
    "published": 1714062193,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024",
    "published": 1714028160,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed Inc Declares New Quarterly Dividend",
    "published": 1714026480,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "RESMED INC Declares Quarterly Dividend",
    "published": 1714026480,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed Non-GAAP EPS of $2.13 beats by $0.22, revenue of $1.2B beats by $30M",
    "published": 1714015920,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed reports Q3 adjusted EPS $2.13, consensus $1.91",
    "published": 1714014840,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "Noteworthy Thursday Option Activity: RMD, MDXG, XOM",
    "published": 1714011480,
    "posting_price": 181.42728909,
    "close_price": 181.7741394,
    "percent_change": 0.19117869
  },
  {
    "title": "ResMed Q3 2024 Earnings Preview",
    "published": 1713932700,
    "posting_price": 184.21206749,
    "close_price": 182.13090515,
    "percent_change": -1.12976439
  },
  {
    "title": "ResMed Inc. stock falls Wednesday, underperforms market",
    "published": 1713931560,
    "posting_price": 184.21206749,
    "close_price": 182.13090515,
    "percent_change": -1.12976439
  },
  {
    "title": "Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "published": 1713880858,
    "posting_price": 180.95157707,
    "close_price": 182.56695557,
    "percent_change": 0.89271314
  },
  {
    "title": "ResMed (RMD) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates",
    "published": 1713791768,
    "posting_price": 178.38483925,
    "close_price": 178.73170471,
    "percent_change": 0.19444784
  },
  {
    "title": "ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "published": 1713448898,
    "posting_price": 175.80815883,
    "close_price": 176.01628113,
    "percent_change": 0.11838034
  },
  {
    "title": "RMD June 21st Options Begin Trading",
    "published": 1713433920,
    "posting_price": 175.80815883,
    "close_price": 176.01628113,
    "percent_change": 0.11838034
  },
  {
    "title": "Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank",
    "published": 1713394313,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Eli Lilly Stock Gains After Study Shows Weight-Loss Drug Combats Sleep Apnea",
    "published": 1713361408,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Eli Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Test; ResMed Dives",
    "published": 1713358653,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Notable Wednesday Option Activity: RMD, HES, STLD",
    "published": 1713357120,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "RBC says small surprise in Lilly's trial could be viewed as positive for ResMed",
    "published": 1713349260,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "ResMed Breaks Below 200-Day Moving Average - Notable for RMD",
    "published": 1713348600,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Inspire rises, ResMed slips as Street digests data from Lilly sleep apnea trials",
    "published": 1713346800,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Inspire Medical rebounds as J.P. Morgan defends after Lilly sleep data",
    "published": 1713346560,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "KeyBanc views Lilly's SURMOUNT-OSA results as 'a bit of a relief' for Inspire",
    "published": 1713341700,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "ResMed, Inspire Medical slip after Lilly sleep apnea trials meet goal",
    "published": 1713340560,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "BTTR, ICCM and SXTC among pre-market losers",
    "published": 1713338820,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder",
    "published": 1713333960,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test",
    "published": 1713330573,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Resmed Stock Poised for Growth: Buy Rating Affirmed Amid Revenue Upswing and Margin Expansion",
    "published": 1713327060,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)",
    "published": 1713326820,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "Wednesday Sector Laggards: Healthcare, Technology & Communications",
    "published": 1713318180,
    "posting_price": 180.36689035,
    "close_price": 172.27020264,
    "percent_change": -4.48900998
  },
  {
    "title": "ResMed AirSense 10 AutoSet: Empowering Sleep Health with Positive Airway Pressure Therapy",
    "published": 1713242171,
    "posting_price": 182.8048282,
    "close_price": 183.20123291,
    "percent_change": 0.21684586
  }
]